NANOPARTICULATE FORMULATION Application WO-2023062353-A1 World Intellectual Property Organisation (WIPO) 20 Apr 2023
FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE Application EP-4112638-A1 European Patent Office 04 Jan 2023
FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE Application WO-2017200852-A1 World Intellectual Property Organisation (WIPO) 23 Nov 2017